Establishing pragmatic estimated GFR thresholds to guide metformin prescribing
- 24 September 2007
- journal article
- Published by Wiley in Diabetic Medicine
- Vol. 24 (10), 1160-1163
- https://doi.org/10.1111/j.1464-5491.2007.02221.x
Abstract
Renal impairment is a contraindication to metformin treatment because of the perceived increased risk of lactic acidosis. Current guidelines define renal impairment according to the serum creatinine of the individual, but this measure is being supplanted by the use of estimated glomerular filtration rate (eGFR) as it gives a closer estimate to true GFR. This study aimed to establish pragmatic eGFR limits for use in patients being considered for metformin treatment. Estimated GFR measurements corresponding to currently used metformin creatinine limits of 130 and 150 micromol/l were derived and then applied to 12 482 patients with diabetes in Hull and East Yorkshire. Few patients with a serum creatinine of 130 or 150 micromol/l have an eGFR of < 30 ml/min/1.73 m(2)[chronic kidney disease (CKD) stage 4 or greater], while most are between 30 and 59 ml/min/1.73 m(2) (CKD stage 3). When applied to the 12 482 patients (median age 67 years, interquartile range 56-75), males predominated when using creatinine cut-offs (13.6% of males and 8.3% of females had creatinine > 130 micromol/l; 8.2% males and 5.2% females > 150 micromol/l), but not using eGFR CKD thresholds (3.3% males and 4.7% females < 30 ml/min/1.73 m(2); 20.8% males and 28.1% females eGFR 30-59 ml/min/1.73 m(2)). Similar proportions of patients as currently would have metformin withheld if using eGFR cut-offs between 30 and 49 ml/min/1.73 m(2). We have proposed pragmatic eGFR limits to guide metformin prescribing in patients with renal impairment. CKD stage 4 or greater should be an absolute contraindication to metformin, while CKD stage 3 should alert clinicians to consider other risk factors before initiating or continuing treatment.Keywords
This publication has 10 references indexed in Scilit:
- Clinical utility of estimated glomerular filtration rates in predicting renal risk in a district diabetes populationDiabetic Medicine, 2006
- Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitusPublished by Wiley ,2006
- Contraindications can damage your health—is metformin a case in point?Diabetologia, 2005
- The Phantom of Lactic Acidosis due to Metformin in Patients With DiabetesDiabetes Care, 2004
- Metformin and lactic acidosis: cause or coincidence? A review of case reportsJournal of Internal Medicine, 2004
- Metformin and serious adverse effectsThe Medical Journal of Australia, 2004
- Contraindications to the use of metforminBMJ, 2003
- A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction EquationAnnals of Internal Medicine, 1999
- Lactic Acidosis Rates in Type 2 DiabetesDiabetes Care, 1998
- Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)The Lancet, 1998